TY  - JOUR 
AU  - Antón, A
AU  - Ruiz, A
AU  - Plazaola, A
AU  - Calvo Martínez, Lourdes
AU  - Seguí, M. A.
AU  - Santaballa, A.
AU  - Muñoz, M.
AU  - Sánchez, P.
AU  - Miguel, A.
AU  - Carrasco, E.
AU  - Lao, J.
AU  - Camps, J.
AU  - Alfaro, J.
AU  - Antolín, S.
AU  - Cámara, M. C.
PY  - 2011
SN  - 0923-7534
UR  - http://hdl.handle.net/20.500.11940/2708
AB  - BACKGROUND:
we previously reported a phase I trial of liposome-encapsulated doxorubicin citrate (LD), docetaxel and trastuzumab as neoadjuvant in stages II and IIIA human epidermal growth factor receptor 2-overexpressing breast cancer patients. This...
LA  - eng
TI  - Phase II clinical trial of liposomal-encapsulated doxorubicin citrate and docetaxel, associated with trastuzumab, as neoadjuvant treatment in stages II and IIIA HER2-overexpressing breast cancer patients. GEICAM 2003-03 study
DO  - 10.1093/annonc/mdq317
T2  - ANNALS OF ONCOLOGY
M2  - 74
VL  - 22
ER  -